Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWO study: Treg cell therapy in living donor kidney transplantation
ISRCTN11038572Phase 2Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of TCK-276 in kidney failure (2 arms), sponsored by University of Oxford. Primary endpoint: Incidence of biopsy-confirmed acute rejection. Started Dec 2018; status: active, not recruiting.
02
Drugs
TCK-276
03
Conditions
kidney failure
Beyond the preview
Go deeper on ISRCTN11038572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11038572.